Search
-
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue -
Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype
(Brain Sciences. vol. 12, n° 2, pp. 183, 2022-01-29)Article de revueOpen access -
Do isolated cognitive relapses exist? Commentary
(Multiple Sclerosis Journal. vol. 27, n° 10, pp. 1489-1490, 2021-09)Article de revueOpen access -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueOpen access -
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueOpen access -
MRI characteristics of MOG-Ab associated disease in adults: an update
(2021)Document de travail - Pré-publicationOpen access -
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
(Multiple Sclerosis and Related Disorders. vol. 48, 2021-02)Article de revueOpen access -
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification among Natalizumab Users in France
(JAMA Neurology. vol. 77, n° 1, pp. 94-102, 2020-01-01)Article de revueOpen access -
Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries
(2022)Document de travail - Pré-publicationOpen access -
Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis
(Frontiers in immunology. vol. 12, 2021-05-04)Article de revueOpen access